Insights · Cataract

IOL selection and refractive targeting: when good intentions lead to litigation.

IOL selection and refractive targeting sit at the intersection of clinical judgement, patient expectation and medico-legal risk. Technically competent surgery may still give rise to claims when expectation management and documentation are inadequate.

Commentary by Professor Irfan Jeeva, Consultant Ophthalmologist and Expert Witness

This article explores how IOL selection and refractive planning are examined retrospectively by the court, and why technically competent surgery may still give rise to claims.

Refractive targeting is no longer a secondary consideration

Historically, cataract surgery was framed as a sight-restoring procedure. Increasingly, patients view it as refractive surgery, with expectations of spectacle independence or precise outcomes. This has changed how courts view refractive planning: IOL selection and target refraction are now central to patient autonomy and informed decision-making. Experts are asked not only whether the chosen IOL was reasonable, but whether the refractive aim itself was appropriately discussed and agreed.

The refractive target is patient specific

A common misconception is that a single refractive target represents a default standard. In practice, targets must be individualised, informed by dependence on the fellow eye, occupational and lifestyle visual demands, tolerance of anisometropia, willingness to use spectacles, pre-existing ocular pathology, and prior refractive history. Failure to explore these can lead to dissatisfaction even when biometry and surgery are technically sound.

First-eye outcomes and second-eye planning

One of the most scrutinised areas in bilateral cases is how the first-eye outcome informed second-eye planning: whether the refractive result was reviewed critically, whether prediction error was acknowledged, whether the second-eye target was adjusted, and whether further discussion took place. Proceeding with an identical plan despite an unexpected outcome may be difficult to defend if no reassessment is documented.

Biometry limitations and refractive uncertainty

Modern biometry is highly accurate, but not infallible. Courts increasingly expect patients to be informed about refractive uncertainty, particularly with extreme axial lengths, prior corneal refractive surgery, corneal irregularity, ocular surface disease, or dense cataract affecting measurements. Experts consider whether unpredictability was foreseeable and clearly communicated.

Premium IOLs and heightened expectation

Toric, multifocal and extended-depth-of-focus lenses add complexity. They may offer advantages but carry specific risks requiring careful counselling: dysphotopsia, reduced contrast sensitivity, intolerance of optical phenomena, the possible need for explantation or exchange, and residual refractive error. Courts scrutinise whether the consent process addressed trade-offs as well as benefits.

Documentation as a reflection of decision-making

In litigation, documentation becomes the proxy for the consultation. Where refractive discussions are not recorded, courts may infer they did not occur. Common deficiencies include no record of the refractive aim, no discussion of spectacle dependence, no note of alternatives such as monovision or deferral, and no reference to refractive uncertainty. Clear, contemporaneous documentation is often decisive.

Causation and refractive dissatisfaction

Unlike vision-threatening complications, refractive disputes often turn on whether the patient would have chosen differently if properly informed: whether the outcome was within an acceptable range, whether dissatisfaction equates to harm, whether alternative targets would likely have produced a better functional outcome, and whether the patient would have declined or chosen differently. This analysis requires careful avoidance of hindsight bias.

Conclusion

IOL selection and refractive targeting fail medico-legally not because of technical incompetence, but because the decision-making process is not sufficiently visible. When refractive planning is treated as a shared decision rather than a technical default, outcomes are more defensible and patient autonomy is better respected.

Frequently asked questions

Why has refractive targeting become central to cataract litigation?

Historically, cataract surgery was framed as a sight-restoring procedure. Increasingly, patients view it as refractive surgery, with expectations of spectacle independence or precise outcomes. This has changed how courts view refractive planning: IOL selection and target refraction are now central to patient autonomy and informed decision-making. Experts are asked not only whether the chosen IOL was reasonable, but whether the refractive aim itself was appropriately discussed and agreed.

How should the refractive target be chosen for an individual patient?

A common misconception is that a single refractive target represents a default standard. In practice, targets must be individualised, informed by dependence on the fellow eye, occupational and lifestyle visual demands, tolerance of anisometropia, willingness to use spectacles, pre-existing ocular pathology, and prior refractive history. Failure to explore these can lead to dissatisfaction even when biometry and surgery are technically sound.

How does causation apply to refractive dissatisfaction after cataract surgery?

Unlike vision-threatening complications, refractive disputes often turn on whether the patient would have chosen differently if properly informed: whether the outcome was within an acceptable range, whether dissatisfaction equates to harm, whether alternative targets would likely have produced a better functional outcome, and whether the patient would have declined or chosen differently. This analysis requires careful avoidance of hindsight bias.